Image Analysis Group and HeartcoR Solutions Form Strategic Partnership to Streamline Clinical Trial Cardiac Safety and Imaging Services
核心洞察
Image Analysis Group (搜索) (IAG) and HeartcoR Solutions (搜索) announced a strategic partnership to deliver integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide.
The collaboration combines HeartcoR's comprehensive core lab services including ECG and cardiac monitoring with IAG's multimodality imaging expertise and DYNAMIKA™ technology platform.
The partnership addresses industry challenges of fragmented data flows and coordination burden by offering a single point of accountability and integrated data delivery across cardiac and imaging endpoints.
Image Analysis Group (搜索) (IAG), a global imaging contract research organization headquartered in London, UK, and HeartcoR Solutions (搜索), LLC, a specialized cardiac safety core lab based in Schaumburg, IL, announced on May 6, 2026, a strategic partnership to deliver fully integrated cardiac safety monitoring and imaging services to pharmaceutical and biotechnology sponsors worldwide.
The partnership combines HeartcoR's comprehensive core lab services, including ECG, cardiac monitoring, and endpoint adjudication, with IAG's multimodality imaging core lab expertise and DYNAMIKA™ technology platform. This integration enables an end-to-end workflow spanning cardiac safety reading, imaging acquisition, and quantitative image analysis within a unified operational and data environment.
Addressing Industry Pain Points
Clinical operations and medical teams frequently source cardiac safety and imaging core lab services from separate vendors, creating fragmented data flows, delays in safety signal detection, and additional coordination burden. The IAG–HeartcoR partnership addresses these challenges through several key innovations.
"Biotech sponsors running complex oncology (搜索), cardiology (搜索), neurology (搜索), and metabolic disorder (搜索) trials consistently tell us they want fewer vendors, faster data access, and higher confidence in their imaging and cardiac endpoints," said Dr. Olga Kubassova, Chief Executive Officer of Image Analysis Group (搜索). "By aligning HeartcoR's cardiac safety expertise with IAG's imaging services and DYNAMIKA™ platform, we are creating a true one-stop solution that streamlines operations and supports stronger safety and efficacy narratives for regulatory submissions."
Integrated Service Offerings
The partnership offers sponsors a single point of accountability through one integrated proposal, aligned governance, and a coordinated team managing both cardiac and imaging data streams. Defined integration pathways have been established between IAG's DYNAMIKA™ cloud platform for imaging data collection, management, and analysis, with HeartcoR's cardiac safety data management systems to enable seamless, auditable data flow across modalities.
"HeartcoR is committed to supporting our clients with comprehensive solutions, innovative tools, and high-quality scientific services," said Ciaran Cooper, Chief Executive Officer of HeartcoR Solutions (搜索). "Partnering with Image Analysis Group (搜索) allows us to offer sponsors an integrated cardiac safety and imaging solution while maintaining the independence and scientific rigor expected from specialist core labs."
Enhanced Safety Monitoring Capabilities
The coordinated review of ECG and cardiac safety data alongside imaging biomarkers provides sponsors with a more holistic view of drug safety and efficacy to support interactions and submissions to global health authorities. This approach enables faster, more complete safety profiles compared to traditional fragmented approaches.
Michael Clark, Chief Operating Officer at IAG, emphasized the operational benefits: "Our CRO and pharma partners increasingly require integrated cardiac and imaging solutions. This collaboration provides access to two independent, scientifically rigorous core labs working as one, reducing operational burden and strengthening the quality and completeness of trial data."
Regulatory Compliance Framework
Both organizations maintain independent GxP-compliant quality systems, including standard operating procedures, audit readiness, and regulatory compliance frameworks aligned with FDA expectations and ICH Good Clinical Practice guidelines. IAG's DYNAMIKA™ platform delivers GxP-validated, FDA 21 CFR Part 11-compliant imaging data management and analysis for clinical trials across oncology (搜索), musculoskeletal (搜索), autoimmune (搜索), neurological, and cardiovascular (搜索) therapeutic areas.
HeartcoR Solutions (搜索) offers deep expertise in 12-Lead ECG, Holter monitoring, TTM event recording including manual devices and implantable loop recorders, and endpoint adjudication for clinical trials spanning Phase I through Phase IV across multiple therapeutic areas. The company provides independent, high-quality cardiac safety services that meet FDA and international regulatory requirements.